1/634
Looks like no tags are added yet.
Name | Mastery | Learn | Test | Matching | Spaced | Call with Kai | Chat |
|---|
No analytics yet
Send a link to your students to track their progress
Registration, medical history, and physical examination.
Scrub the collection site for at least 30 seconds with povidone-iodine or another approved antiseptic.
No more than 10.5 mL of whole blood per kilogram of donor body weight, including samples.
8 weeks.
Aspirin irreversibly impairs platelet function, so the unit should not be the only platelet source but may be part of a platelet pool.
At least 16 years old or the minimum allowed by state law.
No fixed maximum; older donors are evaluated by a physician or according to institutional policy.
37.5°C or 99.5°F.
12.5 g/dL.
38%.
110 lb or 50 kg.
It must be within normal limits according to institutional policy.
Possible exposure to hepatitis, HIV, or malaria.
1 year.
1 year.
When the tattoo was not performed at a state-regulated facility.
1 year.
1 year.
1 year.
1 year.
1 year from completion of therapy or evaluation according to policy.
1 year.
1 year.
Being a visitor or immigrant from a malaria-endemic area or having a previous diagnosis of malaria.
Viral hepatitis after age 11.
Confirmed positive HBsAg or positive HBV NAT.
Repeatedly reactive anti-HBc or anti-HTLV.
Donation of a unit linked to post-transfusion hepatitis, HIV, or HTLV in the recipient.
HCV, HTLV, HIV, or Trypanosoma cruzi infection.
Evidence of parenteral drug use, meaning drug use by injection or another non-oral route.
Family history of CJD or risk of variant CJD.
History of babesiosis.
Acid citrate dextrose, an anticoagulant-preservative solution used for blood collection.
21 days.
35 days.
42 days.
2,3-DPG and ATP, which help restore RBC oxygen-delivery and energy metabolism.
Wash the cells to remove the rejuvenating solution.
At 1 to 6°C if it will be transfused within 24 hours after washing.
A donation collected for transfusion back to the same donor.
No age limit.
At least 11 g/dL.
At least 33%.
Bacteremia, meaning bacteria in the bloodstream.
More than 72 hours before surgery or transfusion.
They must be segregated from allogeneic units and used only for the original donor.
A collection below the expected volume based on donor weight, using the 10.5 mL/kg limit.
Red Blood Cells, Low Volume.
No, components may not be made from that low-volume unit.
A collection method that selectively removes a blood component and returns the remaining components to the donor.
It can collect a therapeutic dose of a component from one donor instead of multiple donors.
Apheresis collection of cells.
Apheresis collection of plasma.
Apheresis collection of platelets.
Apheresis collection of leukocytes, such as granulocytes or mononuclear cells.
At least 2 days apart and not more than 2 times in any 7-day period.
8 weeks.
16 weeks.
The donation must not reduce donor hemoglobin below 10 g/dL or hematocrit below 30%.
Apheresis used to remove a harmful blood component or substance from a patient.
Platelets, leukocytes, RBCs, or plasma substances such as proteins, immune complexes, and high-molecular-weight particles.
Stem cells that can form blood cells and reconstitute bone marrow.
To restore bone marrow after chemotherapy or irradiation or to replace abnormal marrow cells with normal marrow cells.
Congenital immune deficiencies, anemias, malignant bone marrow disorders, and red cell disorders.
Bone marrow, umbilical cord blood, and peripheral blood collected by apheresis.
It lowers the risk of graft-versus-host disease, also called GVHD.
No, ABO compatibility is not required.
ABO typing, with discrepancies resolved before use.
Rh typing with weak D determination when required.
A test for clinically significant unexpected antibodies in donor or patient plasma.
FFP cannot be prepared from units with clinically significant antibodies, and platelets or cryoprecipitate from those units can contain only minimal plasma volume.
RPR, a rapid plasma reagin test.
Anti-Trypanosoma cruzi testing.
HBsAg, anti-HBc, and HBV DNA.
Anti-HCV and HCV RNA.
Anti-HIV-1/2, HIV antigen testing, and HIV RNA testing when required.
Anti-HTLV-I/II.
WNV RNA.
Severe shock with blood loss greater than 25% of blood volume when both oxygen-carrying RBCs and volume replacement are needed.
Component therapy is more available and allows specific component replacement.
A red cell component with most plasma removed.
They provide oxygen-carrying capacity with less volume.
Less than 80% hematocrit.
About 55 to 65% hematocrit.
About 1 g/dL.
About 3 percentage points.
Potassium increases.
Ammonia increases.
pH decreases.
Sodium decreases.
If the unit exceeds 10°C or if the seal has been disturbed.
RBCs washed with saline to remove plasma proteins and other soluble substances.
They remove plasma proteins that can trigger allergic responses.
They reduce plasma IgA and help prevent anaphylactic reactions.
To remove anti-IgA or other plasma substances and reduce risk to the infant.
Complement attached to RBCs or plasma remnants.
24 hours.
More than 60 g hemoglobin in individual units.
More than 50 g hemoglobin in 95% of units tested.
Less than 5 x 10^6 leukocytes per unit.